MARKET

MYGN

MYGN

Myriad Genetics
NASDAQ
5.54
+0.01
+0.18%
After Hours: 5.54 0 0.00% 19:30 11/19 EST
OPEN
5.54
PREV CLOSE
5.53
HIGH
5.74
LOW
5.44
VOLUME
1.17M
TURNOVER
--
52 WEEK HIGH
8.09
52 WEEK LOW
2.740
MARKET CAP
531.41M
P/E (TTM)
-4.0652
1D
5D
1M
3M
1Y
5Y
1D
BillionToOne Faces Short Report Alleging Kickbacks, Flawed Diagnostic Tests
Benzinga · 1d ago
Diagnostic stocks safe from proposed crackdown on Medicare fraud
Seeking Alpha · 2d ago
Myriad Genetics expands collaboration with SRL in Japan
TipRanks · 2d ago
Myriad Genetics Expands Collaboration With SRL To Enable Local Japanese Testing For Its BRACAnalysis Diagnostic System
Benzinga · 2d ago
Weekly Report: what happened at MYGN last week (1109-1113)?
Weekly Report · 3d ago
Myriad Genetics Earnings Call Signals Strategic Shift and Recovery
TipRanks · 5d ago
Myriad Genetics Is Maintained at Equal-Weight by Stephens & Co.
Dow Jones · 11/12 13:48
Myriad Genetics Price Target Raised to $6.00/Share From $3.00 by Stephens & Co.
Dow Jones · 11/12 13:48
More
About MYGN
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health, and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test, which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor, Precise Liquid, SneakPeek and GeneSight, among others.

Webull offers Myriad Genetics Inc stock information, including NASDAQ: MYGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MYGN stock methods without spending real money on the virtual paper trading platform.